+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparative DNA binding of 7,12-dimethylbenz[a]anthracene and some of its metabolites in mouse epidermis in vivo as revealed by the 32P-postlabeling technique



Comparative DNA binding of 7,12-dimethylbenz[a]anthracene and some of its metabolites in mouse epidermis in vivo as revealed by the 32P-postlabeling technique



Carcinogenesis 7(4): 535-540



The binding of some mouse skin metabolites and related derivatives of the tumor initiator 7,12-dimethylbenz[a]anthracene (DMBA) was investigated by 32P-postlabeling analysis after its topical administration. DMBA and trans-3,4-dihydro-3,4-dihydroxy-DMBA (DMBA-3,4-dihydrodiol) both led to the formation of four DNA adducts, which showed a very similar pattern of spots on thin-layer chromatograms. With trans-8,9-dihydro-8,9-dihydroxy-7,12-dimethylbenz[a]anthracene (DMBA-8,9-dihydrodiol) one major adduct was obtained which was chromatographically indistinguishable from one of the DMBA adducts. In contrast, 7-hydroxymethyl-12-methylbenz[a]anthracene (7-OHM-12-MBA) gave rise to two major adducts which were separable from DMBA adducts. 3-hydroxy-7,12-dimethylbenz[a]anthracene (3-OH-DMBA) and 7,12-dimethylbenz[a]anthracene-7,12-epoxide (DMBA-O2) did not lead to detectable amounts of adducts. Quantitative determination of DNA binding showed that an initiating dose (i = 100 nmol) of DMBA yielded approximately 12 adducts/10(7) normal nucleotides. Adduct formation with the same dose of DMBA-3,4-dihydrodiol was 7-8 times higher. At a 4-fold higher dose level, DMBA-8,9-dihydrodiol exhibited a 3- to 6-times weaker binding and 7-OHM-12-MBA a slightly stronger binding than DMBA. Chromatography of the DMBA and DMBA-3,4-dihydrodiol adducts with a solvent containing borate showed a decreased mobility of two out of four adducts in each case. These adducts were also sensitive to oxidation by periodate. The results suggest that two DMBA adducts carried vicinal cis-hydroxyl groups and thus were probably derived from the anti-3,4-dihydrodiol-1,2-oxide(s) of DMBA. The other two adducts were probably derived from the syn-stereoisomer(s). When the DNA-modifying capabilities and initiating activities of the more prominent mouse-skin metabolites are considered in relation to DMBA, DMBA-3,4-dihydrodiol is postulated to be a proximate and DMBA-3,4-dihydrodiol-1,2-oxide(s) to be ultimate initiators.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 039614333

Download citation: RISBibTeXText

PMID: 3084113


Related references

Comparative Dna binding of 7, 12-dimethylbenz[a]anthracene and some of its metabolites in mouse epidermis in vivo as revealed by the 32 P-postlabeling technique. Carcinogenesis 7(4): 535-540, 1986

Comparative dna binding of 7 12 dimethylbenz a anthracene and some of its metabolites in mouse epidermis in vivo as revealed by the phosphorus 32 postlabeling technique. Carcinogenesis 7(4): 535-540, 1986

Comparative binding of 7 12 dimethylbenz a anthracene and some of its metabolites to mouse epidermal dna in vivo as revealed by phosphorus 32 postlabeling. Journal of Cancer Research & Clinical Oncology 109(2): A11, 1985

Inhibition of the binding of 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene to DNA in mouse skin epidermis by 1-ethynylpyrene. Carcinogenesis 11(7): 1139-1143, 1990

Inhibition of the binding of 7,12-dimethylbenz[ a ] anthracene and benzo[ a ] pyrene to Dna in mouse skin epidermis by 1-ethynylprene. Carcinogenesis 11(7): 1139-1143, 1990

32P-postlabeling analysis of DNA adducts persisting for up to 42 weeks in the skin, epidermis and dermis of mice treated topically with 7,12-dimethylbenz[a]anthracene. Carcinogenesis 6(8): 1117-1126, 1985

Covalent binding of 7,12-dimethylbenz(a)anthracene and 10-fluoro-7,12-dimethylbenz(a)anthracene to mouse epidermal DNA and its relationship to tumor-initiating activity. Cancer Research 45(2): 591-597, 1985

Phosphorus 32 postlabeling analysis of dna adducts persisting for up to 42 weeks in the skin epidermis and dermis of mice treated topically with 7 12 dimethylbenz a anthracene. Carcinogenesis 6(8): 1117-1126, 1985

Formation of 7-hydroxymethyl-12-methylbenz(a)anthracene-DNA adducts from 7,12-dimethylbenz(a)anthracene in mouse epidermis. Cancer Research 43(9): 4221-4226, 1983

Syntheses of Metabolites of 7,12-Dimethylbenz[ a ]anthracene. 4-Hydroxy-7,12-dimethylbenz[ a ]anthracene, 7-Hydroxymethyl-12-methylbenz[ a ]anthracene, Their Methyl Ethers, and Acetoxy Derivatives. Journal of Medicinal Chemistry 10(5): 932-936, 1967

Synthesis of metabolites of 7,12-dimethylbenz[a]anthracene. 4-Hydroxy-7,12-dimethylbenz[a]anthracene, 7-hydroxymethyl-12-methylbenz[a]anthracene, their methyl ethers, and acetoxy derivatives. Journal of Medicinal Chemistry 10(5): 932-936, 1967

Characterization of dibenz anthracene-DNA adducts in mouse epidermis by 32P-postlabeling. Proceedings of the American Association for Cancer Research Annual Meeting 35: 112, 1994

Comparative biologic activities of 7,12-dimethylbenz(a)anthracene, 7-hydroxymethyl-12-methylbenz(a)anthracene, 7,12-dehydroxy-methylbenz(a)anthracene, and 4-methoxy-7,12-dimethylbenz(a)anthracene in the Sprague-Dawley female rat. Cancer Research 29(2): 403-408, 1969

Comparative analysis of 7 12 dimethylbenz a anthracene dmba dna adducts by phosphorus 32 postlabeling and by high pressure liquid chromatography hplc. Proceedings of the American Association for Cancer Research Annual Meeting 29: 92, 1988

Characterization of 7-methylbenz anthracene-DNA adducts in mouse epidermis by 32P-Postlabeling coupled to HPLC. Proceedings of the American Association for Cancer Research Annual Meeting 36: 140, 1995